Hip Prosthesis Components Position

NCT ID: NCT05406271

Last Updated: 2022-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hip Prosthesis with intraoperative fluoroscopy

Group Type EXPERIMENTAL

Intraoperative fluoroscopy

Intervention Type DIAGNOSTIC_TEST

Impantation of hip prosthesis with intraoperative fluoroscopy

Hip Prosthesis without intraoperative fluoroscopy

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intraoperative fluoroscopy

Impantation of hip prosthesis with intraoperative fluoroscopy

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indication for hip replacement surgery

Exclusion Criteria

* pregnancy
* abnormal anatomy (hip dysplasia, fracture)
* previous srgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mateusz Szymczak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mateusz Szymczak

MD Phd

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

District Hospital

Rypin, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Karol Elster, MD, Phd

Role: CONTACT

+48662128773

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Karol Elster, MD, Phd

Role: primary

+48662128773

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Selecting the Right Hip Prosthesis for Young Patients
NCT03279276 ACTIVE_NOT_RECRUITING NA
The Medacta Quadra-P Anteverted Study
NCT05460715 ACTIVE_NOT_RECRUITING